Founded in 1997, NeoMed has established five funds and invests in emerging healthcare companies with innovative medical products in the pharmaceutical, medical device, and diagnostics industries. They have successfully invested in over 30 companies in Europe and North America, providing funding at all stages of development. With offices in Norway and Switzerland, NeoMed works closely with its portfolio companies to support their growth. Currently, NeoMed is focused on its NeoMed Innovation IV L.P. and NeoMed Innovation V L.P. funds.